Ventas Inc.: A Long-Term Growth Story With Robust Positioning

About: Ventas, Inc. (VTR)
by: Avisol Capital Partners
This article is exclusive for subscribers.
Avisol Capital Partners
Long/short equity, newsletter provider, healthcare, biotech

Ventas Inc. holds a strong position in the healthcare REIT segment.

The company is going through a high growth phase, putting a strain on its margins.

The stock is trading close to lows but has strong potential ahead.

Since we covered Ventas Inc. (VTR) in August, it has fallen sharply; however, these low prices present an even better opportunity. Ventas is a well-diversified healthcare REIT with interests in different segments. The